Pentamidine

Sodium acetate (Sigma-Aldrich, S2889), C646 (Sigma-Aldrich, SML0002), orlistat (Cayman, 10005426), ACSS2 inhibitor (Millipore, 533756), mithramycin A (Cayman, 11434), pentamidine (Cayman, 20679), ¹⁴C₂-acetic acid, (Perkin Elmer, NEC553050UC), 2-deoxyglucose (Sigma-Aldrich, D8375), 2,4-dinitrophenol (Sigma-Aldrich, D198501), rotenone (Sigma-Aldrich, cat. no. R8875), DAPI (Invitrogen, P36935), Turbofect transfection reagent (Thermo Fisher, R0532), DharmaFECT 1 transfection reagent (Horizon Discovery, T-2001), Nile red (Thermo Fisher, N1142), protein G magnetic beads (Thermo Fisher, 10004D), dispase II (Sigma-Aldrich, D4693), delipidated serum (Biowest, S181L), TRIzol (Thermo Fisher, 15596026), MG132 (EMD Millipore, 474790), PowerUP SYBR Green Mastermix (Applied Biosystems, A25742), MTT (Sigma-Aldrich, M2128), HA-magnetic beads (Thermo Fisher, 88836).

Individual chemicals, i.e., albendazole, alexidine, azelastine, bosutinib, carmofur, cladribine, digoxigenin, dronedarone, emetine, miconazole, pentamidine, pitavastatin, sertraline, solifenacin, sulcanozole, tadalafil, terfenadine, thioridazine, trifluorothymidine, and toremifene were purchased from Cayman Chemical Company (Ann Arbor, MI, USA). Additionally, 10-deacetylbaccatin, allyl-thiourea, aminoacridine, bazedoxifene, cephalomannine, cetrimonium bromide, ciclopirox, clomifene, cytarabine, fenbendazole, ouabain, oxethazaine, penfluridol, pyrithione zinc, tioconazole, thioguanine, and vinorelbine were purchased from Sigma-Aldrich. Flubendazole was purchased from LKT Laboratories, Inc. (St. Paul, MN, USA), and gemcitabine and niclosamide were purchased from AdipoGen^® Life Science (Liestal, Switzerland), whereas thonzonium bromide and pralatrexate were purchased from MedChemExpress (Monmouth Junction, NJ, USA).